| Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with … S Mazloomzadeh, S Khaleghparast, B Ghadrdoost, M Mousavizadeh, ... Jama 325 (16), 1620-1630, 2021 | 682 | 2021 |
| Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the … B Bikdeli, AH Talasaz, F Rashidi, B Sharif-Kashani, M Farrokhpour, ... Thrombosis research 196, 382-394, 2020 | 87 | 2020 |
| Muscle wasting in young patients with dilated cardiomyopathy M Hajahmadi, S Shemshadi, E Khalilipur, A Amin, S Taghavi, M Maleki, ... Journal of Cachexia, Sarcopenia and Muscle 8 (4), 542-548, 2017 | 85 | 2017 |
| Laparoscopic management of paratubal and paraovarian cysts AM Darwish, AF Amin, SA Mohammad JSLS: Journal of the Society of Laparoendoscopic Surgeons 7 (2), 101, 2003 | 81 | 2003 |
| Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION … B Bikdeli, AH Talasaz, F Rashidi, H Bakhshandeh, F Rafiee, P Rezaeifar, ... Thrombosis and haemostasis 122 (01), 131-141, 2022 | 80 | 2022 |
| EVALUATION OF THE SERUM LEVELS OF IMMUNOGLOBULINS AND COMPLEMENT FACTORS IN B-THALASSEMIA MAJOR PATIENTS IN SOUTHERN IRAN AA AMIN, S Jalali, N JAMALIAN, M KARIMI, R AMIN, YS ALE IRANIAN JOURNAL OF IMMUNOLOGY (IJI) 2 (4), 220-225, 2005 | 70 | 2005 |
| Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores R Tadros, HL Tan, ESCAPE-NET Investigators, S el Mathari, JA Kors, ... European heart journal 40 (37), 3097-3107, 2019 | 66 | 2019 |
| Serum uric acid levels correlate with filling pressures in systolic heart failure A Amin, F Vakilian, M Maleki Congestive Heart Failure 17 (2), 79-83, 2011 | 61 | 2011 |
| Can vitamin D supplementation improve the severity of congestive heart failure? A Amin, S Minaee, M Chitsazan, N Naderi, S Taghavi, M Ardeshiri Congestive Heart Failure 19 (4), E22-E28, 2013 | 53 | 2013 |
| Nanoscale technologies for prevention and treatment of heart failure: challenges and opportunities MJ Hajipour, M Mehrani, SH Abbasi, A Amin, SE Kassaian, JC Garbern, ... Chemical reviews 119 (21), 11352-11390, 2019 | 52 | 2019 |
| Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled … A Amin, M Chitsazan, S Taghavi, M Ardeshiri ESC heart failure 2 (1), 5-11, 2015 | 44 | 2015 |
| Liver diseases in heart failure M Maleki, F Vakilian, A Amin Heart Asia 3 (1), 143-149, 2011 | 34 | 2011 |
| The relationship between spiritual health and quality of life of heart transplant candidates S Taghavi, PF Afshar, T Bagheri, N Naderi, A Amin, Y Khalili Journal of religion and health 59, 1652-1665, 2020 | 32 | 2020 |
| Pheochromocytoma-induced reverse tako-tsubo with rapid recovery of left ventricular function N Naderi, A Amin, A Setayesh, H Pouraliakbar, K Mozaffari, M Maleki Cardiology Journal 19 (5), 527-531, 2012 | 32 | 2012 |
| Quantitative assessment of right atrial function by strain and strain rate imaging in patients with heart failure ZO Haghighi, N Naderi, A Amin, S Taghavi, M Sadeghi, H Moladoust, ... Acta cardiologica 66 (6), 737-742, 2011 | 32 | 2011 |
| Assessment of left ventricular mechanical dyssynchrony by phase analysis of gated-SPECT myocardial perfusion imaging and tissue Doppler imaging: comparison between QGS and ECTb … F Rastgou, M Shojaeifard, A Amin, T Ghaedian, H Firoozabadi, H Malek, ... Journal of Nuclear Cardiology 21 (6), 1062-1071, 2014 | 31 | 2014 |
| Is chronic sildenafil therapy safe and clinically beneficial in patients with systolic heart failure? A Amin, E Mahmoudi, H Navid, M Chitsazan Congestive heart failure 19 (2), 99-103, 2013 | 31 | 2013 |
| COMPARE CPM-RMI trial: intramyocardial transplantation of autologous bone marrow-derived CD133+ cells and MNCs during CABG in patients with recent MI: a phase II/III … MH Naseri, H Madani, SHA Tafti, MM Farahani, DK Saleh, ... Cell Journal (Yakhteh) 20 (2), 267, 2018 | 29 | 2018 |
| Insulin resistance in pulmonary arterial hypertension, is it a novel disease modifier? N Naderi, P Boobejame, H Bakhshandeh, A Amin, S Taghavi, M Maleki Research in cardiovascular medicine 3 (3), 1-8, 2014 | 27 | 2014 |
| Validity and reliability of a virtual education satisfaction questionnaire from the perspective of cardiology residents during the COVID-19 pandemic B Ghadrdoost, P Sadeghipour, A Amin, H Bakhshandeh, F Noohi, ... Journal of Education and Health Promotion 10, 2021 | 26 | 2021 |
